A PHASE I TRIAL USING PATUPILONE (EPOTHILONE B) AND CONCURRENT

被引：0
|
作者：
Fogh, Shannon E.
Machtay, Mitchell
Werner-Wasik, Maria
Curran, Walter
Bonanni, Roseann
Axelrod, Rita
Andrews, David W.
Dicker, Adam P.
机构：
来源：
NEURO-ONCOLOGY | 2009年 / 11卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：663 / 663
页数：1
相关论文
共 50 条
  • [31] Phase I dose optimization trial of patupilone in previously treated patients (pts) with advanced colon cancer (ACC).
    Melichar, B
    Tabernero, J
    Casado, E
    Bridgewater, J
    Hamm, J
    Sklenar, I
    Holland, J
    Cheung, W
    Zaknoen, S
    Johri, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 292S - 292S
  • [32] A phase lb and pharmacokinetic trial of patupilone combined with carboplatin in patients with advanced cancer
    Forster, Martin
    Kaye, Stan
    Oza, Amit
    Sklenar, Ivo
    Johri, Anandhi
    Cheung, Wing
    Zaknoen, Sara
    Gore, Martin
    CLINICAL CANCER RESEARCH, 2007, 13 (14) : 4178 - 4184
  • [33] PHASE II TRIAL OF PATUPILONE IN PATIENTS WITH BREAST CANCER BRAIN METASTASES
    Peereboom, D. M.
    Conlin, A. K.
    Seidman, A. D.
    Brewer, C.
    NEURO-ONCOLOGY, 2008, 10 (06) : 1077 - 1077
  • [34] Clinical activity of patupilone in patients with pretreated advanced/metastatic colon cancer: results of a phase I dose escalation trial
    Melichar, B.
    Casado, E.
    Bridgewater, J.
    Bennouna, J.
    Campone, M.
    Vitek, P.
    Delord, J-P
    Cerman, J., Jr.
    Salazar, R.
    Dvorak, J.
    Sguotti, C.
    Urban, P.
    Viraswami-Appanna, K.
    Tan, E.
    Tabernero, J.
    BRITISH JOURNAL OF CANCER, 2011, 105 (11) : 1646 - 1653
  • [35] Efficacy and safety of patupilone in non-small cell lung cancer (NSCLC):: A phase I/II trial.
    Sanchez, J. M.
    Mellemgaard, A.
    Perry, M.
    Zatloukal, P.
    Hamm, J.
    Belani, C. P.
    Kim, E.
    Felip, E.
    Berton, M.
    Johri, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 390S - 390S
  • [36] A Phase I Trial of a Methionine Restricted Diet with Concurrent Radiation Therapy
    Mattes, Malcolm D.
    Koturbash, Igor
    Leung, Calvin N.
    Wen, Sijin
    Jacobson, Geraldine M.
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2024, 76 (06): : 463 - 468
  • [37] A phase I trial using the proteasome inhibitor bortezomib and concurrent temazolomide and radiotherapy for high grade gliomas
    Dicker, A.
    Werner-Wasik, M.
    Machtay, M.
    Mallon, G.
    Ramirez, M.
    Andrews, D.
    Curran, J., Jr.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [38] Phase I trial using the proteasome inhibitor bortezomib (velcade) and concurrent chemoradiotherapy for head and neck malignancies
    Fogh, S. E.
    Kubicek, G. J.
    Machtay, M.
    Axelrod, R.
    Anne, R.
    Mallon, G.
    Keane, W. M.
    Myers, T.
    Curran, W. J.
    Dicker, A. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S376 - S377
  • [39] Phase I Trial Using the Proteasome Inhibitor Bortezomib and Concurrent Chemoradiotherapy for Head-and-Neck Malignancies
    Kubicek, Gregory J.
    Axelrod, Rita S.
    Machtay, Mitchell
    Ahn, Peter H.
    Anne, Pramila R.
    Fogh, Shannon
    Cognetti, David
    Myers, Thomas J.
    Curran, Walter J., Jr.
    Dicker, Adam P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (04): : 1192 - 1197
  • [40] A Phase II Trial of the Epothilone B Analog Ixabepilone (BMS-247550) in Patients with Metastatic Melanoma
    Ott, Patrick A.
    Hamilton, Anne
    Jones, Amanda
    Haas, Naomi
    Shore, Tsiporah
    Liddell, Sandra
    Christos, Paul J.
    Doyle, L. Austin
    Millward, Michael
    Muggia, Franco M.
    Pavlick, Anna C.
    PLOS ONE, 2010, 5 (01):
12345